This topic contains a solution. Click here to go to the answer

Author Question: The number below the circle in the figure above indicates the _____. a. number of welds b. ... (Read 16 times)

Destiiny22

  • Hero Member
  • *****
  • Posts: 557
/
  The number below the circle in the figure above indicates the _____.
 
  a. number of welds
  b. size of weld
  c. size of pipe
  d. weld pitch

Question 2

/
  The symbol in the figure above that indicates the weld must be concave in shape is _____.
 
  a. Symbol A
  b. Symbol B
  c. Symbol C
  d. Symbol D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cici

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

a

Answer to Question 2

c




Destiiny22

  • Member
  • Posts: 557
Reply 2 on: Jul 24, 2018
Gracias!


milbourne11

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The largest baby ever born weighed more than 23 pounds but died just 11 hours after his birth in 1879. The largest surviving baby was born in October 2009 in Sumatra, Indonesia, and weighed an astounding 19.2 pounds at birth.

Did you know?

The most common childhood diseases include croup, chickenpox, ear infections, flu, pneumonia, ringworm, respiratory syncytial virus, scabies, head lice, and asthma.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Signs and symptoms that may signify an eye tumor include general blurred vision, bulging eye(s), double vision, a sensation of a foreign body in the eye(s), iris defects, limited ability to move the eyelid(s), limited ability to move the eye(s), pain or discomfort in or around the eyes or eyelids, red or pink eyes, white or cloud spots on the eye(s), colored spots on the eyelid(s), swelling around the eyes, swollen eyelid(s), and general vision loss.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library